Home » Topics » BioWorld Science

BioWorld Science
RSS

NicOx presents new compounds for eye disorders

Jan. 2, 2019

Patient enrollment ongoing in phase I study of BOS-172738

Jan. 2, 2019

Epigenetic analysis boosts malaria pathogenesis understanding

Jan. 2, 2019

ST-8116 demonstrates promising antitumor activity in preclinical models of colon cancer

Jan. 2, 2019

Genetic diversity makes for better Alzheimer's model

Jan. 2, 2019

Sleeping sickness parasite can make its own sugar

Jan. 2, 2019

AOH-1160 demonstrates promising anticancer activity without significant toxicity in vivo

Jan. 2, 2019

Novel selective azaindole TGF-beta receptor kinase inhibitors may improve immuno-oncology therapy

Jan. 2, 2019

Discovery of osimertinib analogue that selectively inhibits EGFR for NSCLC treatment

Jan. 2, 2019

Methylscape alteration of DNA physicochemical properties can be applied for cancer diagnostic assays

Jan. 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...